Fostamatinib combined with TPO‐RAs or steroids as a bridge to monotherapy or as time‐limited continuous treatment in relapsed chronic ITP: A single‐centre case series

Documenti analoghi

• Combining an immunomodulatory drug with a TPO‐RA to treat multirefractory ITP patients: The Spanish ITP Group experience
  di: María‐Eva Mingot‐Castellano, et al.
  Pubblicazione: (2026)
• Toxicity due to steroid treatment in ITP remains a concern
  di: Henrik Frederiksen
  Pubblicazione: (2024)
• Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis
  di: Deevyashali Parekh, et al.
  Pubblicazione: (2024)
• Bendamustine in combination with gemcitabine and vinorelbine as salvage regimen for relapsed or refractory peripheral T‐cell lymphomas: A retrospective single‐centre experience
  di: Filippo Bagnoli, et al.
  Pubblicazione: (2026)
• Evans syndrome: Disease awareness and clinical management in a nation‐wide ITP‐NET survey
  di: Bruno Fattizzo, et al.
  Pubblicazione: (2024)